Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/28/2006 | US7141656 In situ screening, isolation of peptides; major histocompability complex |
11/28/2006 | US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders |
11/28/2006 | US7141652 Antibodies to PRO1561 polypeptide |
11/28/2006 | US7141651 Multiple cytokine protein complexes |
11/28/2006 | US7141547 Albumin fusion proteins comprising GLP-1 polypeptides |
11/28/2006 | US7141435 Monoclonal antibodies against human apoptosis inhibitory protein NAIP and method for assaying the NAIP |
11/28/2006 | US7141424 Solely pollen-specific promoter |
11/28/2006 | US7141422 Transgenic trees exhibiting increased growth, biomass production and xylem fibre length, and methods for their production |
11/28/2006 | US7141421 Control of metabolism with human 2-oxoglutarate carrier |
11/28/2006 | US7141420 Retina specific; for inhibition of macular degeneration |
11/28/2006 | US7141419 Isolated nucleic acids encoding cyclic nucleotide-gated cation channel subunit 3B (CNG3B) polypeptides |
11/28/2006 | US7141418 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
11/28/2006 | US7141410 Methods and materials for the production of organic products in cells of Candida species |
11/28/2006 | US7141409 Hyaluronan synthase gene and uses thereof |
11/28/2006 | US7141404 Candida kefyr cytosine deaminase |
11/28/2006 | US7141389 Chromosome DNA coding for human hepatocyte growth factor |
11/28/2006 | US7141383 EDG8 receptor, its preparation and use |
11/28/2006 | US7141365 Methods for diagnosing a mucin production associated disease condition |
11/28/2006 | US7141363 Purposeful movement of human migratory cells away from an agent source |
11/28/2006 | US7141267 High oleic/high stearic sunflower oils |
11/28/2006 | US7141243 gM-negative EHV-mutants without heterologous elements |
11/28/2006 | US7141242 Hepatitis B virus surface antigen mutant and methods of detection thereof |
11/28/2006 | US7141240 Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding GLP-1 |
11/28/2006 | CA2294355C Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins |
11/28/2006 | CA2282394C Retroviral vectors, methods for their preparation and their use for gene transfer into cd4-positive cells |
11/28/2006 | CA2226968C Novel monoclonal antibody, and immunological assay of e-d-dimer and e-dd/e complex |
11/28/2006 | CA2178984C Novel antibody compositions for preparing enriched human hematopoietic cell preparations |
11/28/2006 | CA2114636C Recombinant plant viral nucleic acids |
11/28/2006 | CA2076345C Transgenic animals, cells and cell lines therefrom, and their use |
11/28/2006 | CA2052792C Method and composition for increasing sterol accumulation in higher plants |
11/28/2006 | CA2026915C Stem cell factor |
11/28/2006 | CA1341516C Preparation of factor x111a by gene manipulation |
11/27/2006 | CA2547845A1 Amniotic fluid derived cells |
11/23/2006 | WO2006125065A2 Resistance to soybean aphid in early maturing soybean germplasm |
11/23/2006 | WO2006124932A2 Kinase peptides and antibodies |
11/23/2006 | WO2006124412A2 Methods for the rapid expansion of antigen specific t-cells |
11/23/2006 | WO2006124356A2 Method for isolating dermal papilla cells and uses thereof |
11/23/2006 | WO2006124269A2 Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders |
11/23/2006 | WO2006123926A2 Peptide composition for growing and/or culturing micro-organisms and/or cells |
11/23/2006 | WO2006123829A1 ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES |
11/23/2006 | WO2006123827A1 Method for amelioration of disease condition induced by mood disorder |
11/23/2006 | WO2006123745A1 Process for production of l-serine derivative and enzyme used in the process |
11/23/2006 | WO2006123699A1 Inducer of differentiation of stem cell into osteoblast |
11/23/2006 | WO2006123658A1 Cell culture substrate, culture apparatus and cell culture method |
11/23/2006 | WO2006123579A1 Method of preparing cell for bone tissue formation and application of cell for bone tissue formation |
11/23/2006 | WO2006123537A1 Novel endoribonuclease |
11/23/2006 | WO2006123004A1 Endothelized artificial matrix comprising a fibrin gel, which is a superproducer of proangiogenic factors |
11/23/2006 | WO2006122854A1 Therapeutic compositions comprising embryonic stem cells of mice |
11/23/2006 | WO2006122442A1 Piggybac as a tool for genetic manipulation and analysis in vertebrates |
11/23/2006 | WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
11/23/2006 | WO2006094286A3 Adult pancreatic derived stromal cells |
11/23/2006 | WO2006088747A3 Serum-free reagents for the isolation, cultivation, and cryopreservation of postnatal pluripotent epiblast-like stem cells |
11/23/2006 | WO2006073839A3 Acid fungal proteases |
11/23/2006 | WO2006060719A3 Use of endosialin binding proteins to isolate endosialin positive cells |
11/23/2006 | WO2006052510A3 Methods for identifying novel modulators of insulin signaling |
11/23/2006 | WO2006027622A3 Transglutaminase crosslinked collagen biomaterial for medical implant materials |
11/23/2006 | WO2005086967A3 Therapeutic use of rm1 antigen |
11/23/2006 | US20060265787 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
11/23/2006 | US20060265785 Isolated polynucleotide having a nucleotide sequence encoding a polypeptide with 1-deoxy-D-xylulose 5-phosphate reductoisomerase activity |
11/23/2006 | US20060265783 growth modulators; modifying RKS genes or gene products as found in Arabidopsis thaliana or other plants; method for increasing organ size or rate of cell division of a plant or plant cell |
11/23/2006 | US20060265782 Novel plant transcribed regions and uses thereof |
11/23/2006 | US20060265779 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
11/23/2006 | US20060265778 Plants and seeds of corn variety ex6077 |
11/23/2006 | US20060265777 Regulatory regions from Papaveraceae |
11/23/2006 | US20060265775 Method for generating plant diversity by incorporation of microsatellite sequences into the plant genome |
11/23/2006 | US20060265774 culture contains glial cell-derived neurotrophic factor, neurturin, and leukemia inhibitory factor |
11/23/2006 | US20060265767 Compositions and methods for treatment of autoimmune and related diseases |
11/23/2006 | US20060264690 Magnetic cell and method of using the same |
11/23/2006 | US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay |
11/23/2006 | US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis |
11/23/2006 | US20060264612 Optimised protein synthesis |
11/23/2006 | US20060264609 Use of heat shock proteins |
11/23/2006 | US20060264392 Modulators of angiogenesis |
11/23/2006 | US20060263883 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
11/23/2006 | US20060263882 Multi-cistronic vectors for gene transfer protocols |
11/23/2006 | US20060263881 Methods of expanding and selecting disease associated T-Cells |
11/23/2006 | US20060263880 Protein factors supporting undifferentiated growth of human embryonic stem cells |
11/23/2006 | US20060263879 Methods and systems relating to embryonic stem cell lines |
11/23/2006 | US20060263878 Cell culture medium and solidified preparation of cell adhesion protein or peptide |
11/23/2006 | US20060263877 Novel megakaryocytic protein tyrosine kinase 1 |
11/23/2006 | US20060263876 Neural crest stem cells and uses thereof |
11/23/2006 | US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety |
11/23/2006 | US20060263854 Immunodiagnostic assays using reducing agents |
11/23/2006 | US20060263853 Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders |
11/23/2006 | US20060263852 Asp2 |
11/23/2006 | US20060263831 Interfacial biomaterials for binding ceramic substrates |
11/23/2006 | US20060263830 Interfacial biomaterials |
11/23/2006 | US20060263829 Efficient haploid cell sorting flow cytometer systems |
11/23/2006 | US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances |
11/23/2006 | US20060263802 Antigenic peptides of rabies virus and uses thereof |
11/23/2006 | US20060263764 Methods and constructs for evaluation of rnai targets and effector molecules |
11/23/2006 | US20060263762 Cytoskeletal integrity testing as a filter for creating homogeneous samples for further analysis |
11/23/2006 | US20060263407 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; stent implants |
11/23/2006 | US20060263403 Compositions and methods for controlling insects involving the tyramine receptor |
11/23/2006 | US20060263391 Process for the preparation of hypoallergenic mosaic antigens |
11/23/2006 | US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
11/23/2006 | US20060263377 Surface protein of Leptospira |
11/23/2006 | US20060263376 Pharmaceutical composition comprising PIM-activated NKT cells, and use thereof in therapy |
11/23/2006 | US20060263361 Pan-kir2dl nk -receptor antibodies and their use in diagnostik and therapy |
11/23/2006 | US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases |